Greenwich LifeSciences Inc (GLSI)
14.39
+0.40
(+2.86%)
USD |
NASDAQ |
May 03, 16:00
14.37
-0.02
(-0.14%)
After-Hours: 20:00
Greenwich LifeSciences 1 Year Total Returns (Daily): 25.02% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 25.02% |
May 02, 2024 | 27.65% |
May 01, 2024 | 23.46% |
April 30, 2024 | 15.97% |
April 29, 2024 | 17.65% |
April 26, 2024 | 23.31% |
April 25, 2024 | 13.63% |
April 24, 2024 | 12.58% |
April 23, 2024 | 14.36% |
April 22, 2024 | 10.44% |
April 19, 2024 | 8.25% |
April 18, 2024 | 15.71% |
April 17, 2024 | 9.94% |
April 16, 2024 | 22.10% |
April 15, 2024 | 20.75% |
April 12, 2024 | 35.50% |
April 11, 2024 | 31.53% |
April 10, 2024 | 25.14% |
April 09, 2024 | 26.66% |
April 08, 2024 | 25.29% |
April 05, 2024 | 36.21% |
April 04, 2024 | 39.69% |
April 03, 2024 | 34.24% |
April 02, 2024 | 26.83% |
April 01, 2024 | 38.07% |
Date | Value |
---|---|
March 28, 2024 | 53.15% |
March 27, 2024 | 44.61% |
March 26, 2024 | 53.82% |
March 25, 2024 | 47.24% |
March 22, 2024 | 52.92% |
March 21, 2024 | 37.20% |
March 20, 2024 | 45.76% |
March 19, 2024 | 30.69% |
March 18, 2024 | 31.30% |
March 15, 2024 | 35.45% |
March 14, 2024 | 29.39% |
March 13, 2024 | 39.04% |
March 12, 2024 | 57.84% |
March 11, 2024 | 45.87% |
March 08, 2024 | 12.54% |
March 07, 2024 | 20.45% |
March 06, 2024 | -5.24% |
March 05, 2024 | -14.66% |
March 04, 2024 | -12.02% |
March 01, 2024 | -17.25% |
February 29, 2024 | -22.10% |
February 28, 2024 | -22.61% |
February 27, 2024 | -16.16% |
February 26, 2024 | -18.27% |
February 23, 2024 | -18.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.64%
Minimum
Jun 16 2022
953.6%
Maximum
Nov 02 2021
27.94%
Average
-27.88%
Median
Mar 03 2022
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 71.87% |
QuidelOrtho Corp | -54.41% |
Outlook Therapeutics Inc | -61.61% |
Gain Therapeutics Inc | -42.64% |
CEL-SCI Corp | -27.23% |